Literature DB >> 22648292

Pathological implications of areas of lower enhancement on contrast-enhanced computed tomography in renal-cell carcinoma: additional information for selecting candidates for surveillance protocols.

Miguel Villalobos-Gollás1, Bernardo Aguilar-Davidov, Carolina Culebro-García, Martha O Gómez-Alvarado, Priscila Rojas-Garcia, Raúl Ibarra-Fombona, Norma Uribe-Uribe, Guillermo Feria-Bernal, Ricardo Castillejos-Molina, Mariano Sotomayor, Fernando Gabilondo, Francisco Rodríguez-Covarrubias.   

Abstract

PURPOSE: Areas of lower enhancement on computed tomography are frequently seen in renal-cell carcinoma. We investigated whether tumor enhancement on the most prominent hypodense areas correlates with the nuclear grade and other pathologic variables.
METHODS: From 2004 to 2009, all consecutive patients with a preoperative tomography who underwent radical or partial nephrectomy for renal-cell carcinoma at our tertiary referral center were retrospectively analyzed. Enhancement of the entire tumor on the slice with most prominent areas of lower enhancement was determined.
RESULTS: Forty-eight patients were included. Clear-cell carcinoma comprised 91.6 %. Mean areas of lower enhancement for nuclear grade tumors 1-4 were 67.4, 38.7, 27.9, and 15.1 HU, respectively. Areas of lower enhancement negatively correlated with size, nuclear grade, T stage, and pathological stage. Tumors with extension beyond Gerota's fascia (10.5 vs. 35.9 HU, p < 0.001) and positive surgical margins (21.2 vs. 34.8 HU, p = 0.04) had more prominent areas of lower enhancement than organ-confined tumors. When comparing nuclear grade 1-3 to nuclear grade 4 tumors, these areas were significantly lower in the later (36.5 vs. 15.1 HU, p < 0.001). Receiver-operating characteristics curves for detecting nuclear grade 4 showed an area under the curve of 0.808 (95 % CI 0.659-0.957).
CONCLUSIONS: Lower enhancement of the entire tumor at the point where hypodense tumor areas are more predominant on tomography is associated with higher nuclear grade and more advanced stage.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22648292     DOI: 10.1007/s11255-012-0199-8

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  20 in total

1.  Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: a Swiss experience with 588 tumors.

Authors:  H Moch; T Gasser; M B Amin; J Torhorst; G Sauter; M J Mihatsch
Journal:  Cancer       Date:  2000-08-01       Impact factor: 6.860

2.  Epidemiologic trends in renal cell carcinoma in the cytokine and post-cytokine eras: a registry analysis of 28,252 patients.

Authors:  Derek Shek; Benjamin Tomlinson; Monica Brown; Ann Brunson; Chong-Xian Pan; Primo N Lara
Journal:  Clin Genitourin Cancer       Date:  2012-02-28       Impact factor: 2.872

3.  Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.

Authors:  John S Lam; Oleg Shvarts; Jonathan W Said; Allan J Pantuck; David B Seligson; Michael E Aldridge; Matthew H T Bui; Xueli Liu; Steve Horvath; Robert A Figlin; Arie S Belldegrun
Journal:  Cancer       Date:  2005-06-15       Impact factor: 6.860

4.  Cancer statistics, 2012.

Authors:  Rebecca Siegel; Deepa Naishadham; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2012-01-04       Impact factor: 508.702

5.  Extensive necrosis in renal cell carcinoma specimens: potential clinical and prognostic implications.

Authors:  I Leibovitch; R Lev; Y Mor; J Golomb; Z A Dotan; J Ramon
Journal:  Isr Med Assoc J       Date:  2001-08       Impact factor: 0.892

6.  Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness.

Authors:  Shomik Sengupta; Christine M Lohse; Bradley C Leibovich; Igor Frank; R Houston Thompson; W Scott Webster; Horst Zincke; Michael L Blute; John C Cheville; Eugene D Kwon
Journal:  Cancer       Date:  2005-08-01       Impact factor: 6.860

7.  Renal cell carcinoma: a clinicopathological follow-up study after radical nephrectomy.

Authors:  Dragomir P Zubac; Leif Bostad; Charlotta Gestblom; Björn Kihl; Tomas Seidal; Tore Wentzel-Larsen; August M Bakke
Journal:  Scand J Urol Nephrol       Date:  2007

8.  Renal cell carcinoma: correlation of CT findings with nuclear morphologic grading in 100 tumors.

Authors:  B A Birnbaum; M A Bosniak; G A Krinsky; D Cheng; J Waisman; M M Ambrosino
Journal:  Abdom Imaging       Date:  1994 May-Jun

9.  Renal cell carcinoma. II. Histological indicators of prognosis.

Authors:  B Delahunt; J N Nacey
Journal:  Pathology       Date:  1987-07       Impact factor: 5.306

Review 10.  Update on radiological imaging of renal cell carcinoma.

Authors:  Deirdre M Coll; Robert C Smith
Journal:  BJU Int       Date:  2007-05       Impact factor: 5.588

View more
  3 in total

1.  Advances of multidetector computed tomography in the characterization and staging of renal cell carcinoma.

Authors:  Athina C Tsili; Maria I Argyropoulou
Journal:  World J Radiol       Date:  2015-06-28

2.  A CT-Based Radiomics Nomogram Integrated With Clinic-Radiological Features for Preoperatively Predicting WHO/ISUP Grade of Clear Cell Renal Cell Carcinoma.

Authors:  Yingjie Xv; Fajin Lv; Haoming Guo; Zhaojun Liu; Di Luo; Jing Liu; Xin Gou; Weiyang He; Mingzhao Xiao; Yineng Zheng
Journal:  Front Oncol       Date:  2021-12-03       Impact factor: 6.244

3.  CT prediction of the Fuhrman grade of clear cell renal cell carcinoma (RCC): towards the development of computer-assisted diagnostic method.

Authors:  Hannu Huhdanpaa; Darryl Hwang; Steven Cen; Brian Quinn; Megha Nayyar; Xuejun Zhang; Frank Chen; Bhushan Desai; Gangning Liang; Inderbir Gill; Vinay Duddalwar
Journal:  Abdom Imaging       Date:  2015-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.